0 followers
Vyro develops oncolytic viruses designed to target CNS tumors, based on pioneering research on the oncolytic properties of the Zika Virus.
Tessera Therapeutics
2 followers
89bio
2 followers
Kyverna Therapeutics
7 followers
Queen Mary University
6 followers
Ventyx Biosciences
1 follower
Longeveron
1 follower
Heartman House Consulting
12 followers
Astria Therapeutics
1 follower
ADARx Pharmaceuticals
3 followers
Rapport Therapeutics
1 follower
Thermo Fisher Scientific
179 followers
Explore companies